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ABSTRACT Birth defects contribute up to 21% of the mortality in those under 5 years of age in Latin America and the Carib-
bean (LAC), and that burden has been compounded by the Zika virus epidemic. In 2001, the March of Dimes 
launched a series of biennial assemblies called the International Conference on Birth Defects and Disabilities 
in the Developing World (ICBD). The latest ICBD, in 2017, convened in Bogotá, Colombia, and was attended 
by over 300 professionals, policymakers, and donors. The conference attendees, a majority of whom were from 
LAC, supported a call to action in the form of a consensus statement. The consensus statement lists key actions 
for maximizing birth defects surveillance, prevention, and care in LAC: 1) improving surveillance; 2) reducing 
risks for birth defects; 3) fortifying staple foods; 4) preventing and treating infections associated with birth 
defects; 5) implementing newborn screening; 6) providing care and services for people with birth defects and 
disabilities; 7) involving governments, civil society, and international agencies; and 8) advancing research for 
birth defects. Implementation and scale-up of evidence-based interventions using multisectoral and multidisci-
plinary collaborative approaches were endorsed. LAC countries can leverage technology and social media to 
advance and advocate for approaches identified in the consensus statement. The consensus statement can be 
used as a guide by both governments and nongovernmental agencies to take immediate steps for improving 
the quality of life of those living with birth defects and associated disabilities in the LAC countries.
Keywords Congenital abnormalities; epidemiology; medical care; neonatal screening; prenatal diagnosis; primary pre-
vention; surveillance; Latin America; West Indies.
Birth defects contribute up to 21% of under-5 mortality in 
Latin America and the Caribbean (LAC), compared to a global 
average of 9% (1). The burden has been further compounded 
by the recent Zika virus epidemic in LAC (2, 3). The United 
Nations Development Program (UNDP) and its partners 
estimated the social and economic impact of Zika alone in 
LAC would be between US$ 7 billion and US$ 18 billion over 
the period 2015–2017 (4). The cost of inaction on birth defects 
for individuals, families, and the society at large cannot be 
ignored.
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At the 63rd World Health Assembly, in 2010, a resolution on 
birth defects was passed to address widespread concerns related 
to lack of recognition of the global burden of birth defects and 
the limited resources for prevention and management of birth 
defects (5). The resolution urged Member States of the World 
Health Organization (WHO) to take steps in prioritizing birth 
defects surveillance, prevention, and care. It called on govern-
ments, civil society, and the public to raise awareness about 
the importance of birth defects, and to mobilize policy and 
programs to reduce morbidity and mortality associated with 
birth defects by integrating birth defects into existing maternal, 
reproductive, and child health services. Additionally, emphasis 
was placed on the social welfare of all individuals with birth 
defects.
Efforts on birth defects have also recently been energized 
with the launch of the Sustainable Development Goals (SDGs) 
(6). Given the burden of birth defects and disability in LAC, it is 
not possible to meet SDG 3.2 (“by 2030, end preventable deaths 
of newborns and children under 5 years of age, with all coun-
tries aiming to reduce neonatal mortality to at least as low as 
12 per 1 000 live births and under-5 mortality to at least as low 
as 25 per 1 000 live births”) and SDG 4.2.1 (“proportion of chil-
dren under 5 years of age who are developmentally on track in 
health, learning and psychosocial well-being, by sex”) without 
addressing the birth defects and related disability. In alignment 
with SDG 3 of health for all, there is a need for immediate action 
to maximize birth defects surveillance, prevention, and care in 
LAC, so as to increase the chances for each pregnancy to have a 
healthy outcome and for an improved quality of life for popula-
tions affected by birth defects and related disabilities.
In 2001, recognizing the need to build capacity in lower-in-
come countries for the prevention of birth defects and care 
of those affected, the March of Dimes (an organization in the 
United States of America that promotes the health of all moth-
ers and babies worldwide (www.marchofdimes.org)), launched 
a series of biennial assemblies called the International Confer-
ence on Birth Defects and Disabilities in the Developing World 
(ICBD). The goal of these events has been to provide a platform 
for the sharing of resources and knowledge to strengthen sur-
veillance and health care delivery for prevention and care, to 
influence public health policy, and to mobilize funding for birth 
defects in countries worldwide. The latest ICBD, in 2017 in 
Bogotá, Colombia, was attended by over 300 professionals, pol-
icymakers, and donors from 31 countries worldwide (7). About 
60% of the participants were from LAC.
The participants at the ICBD 2017 conference agreed that there 
was a need to publish a consensus statement on birth defects 
specific to the LAC countries. In addition, the conference pro-
ceedings highlighted the need to consider the cost-effectiveness 
and the cost-benefit of the proposed actions. Overall, there was 
a general agreement to the call to action described below for 
improving surveillance and prevention of birth defects, increas-
ing access to quality medical care and services, and enhancing 
the role of the civil society in advocating for an increased qual-
ity of life for those affected by birth defects.
A panel of 15 individuals with birth defects expertise in LAC, 
and who were also present at the ICBD 2017, provided input for 
developing a consensus statement specific to LAC. The auth-
ors then shared the original concepts that formed the content 
of the consensus statement with the conference participants, 
seeking their endorsement. A total of 130 participants endorsed 
the original concepts. The majority of those who endorsed the 
concepts were from LAC countries, including Argentina, Bra-
zil, Colombia, Costa Rica, Ecuador, and Uruguay. The following 
call to action is for maximizing birth defects surveillance, pre-
vention, and care in LAC. The call to action is followed by a 
discussion section that provides background on and describes 
the importance of the 2017 consensus statement.
THE CALL TO ACTION
Improving surveillance
1. Ensuring consistency in terminology for defining, coding, 
and classifying birth defects; standardizing data collection 
tools and processes; assuring data integrity through qual-
ity management, training, monitoring, and evaluation; and 
forging collaborations between surveillance systems for 
timely identification and coordinated response to epidemics.
2. Expanding surveillance systems to increase geographic 
and population coverage while ensuring that functional or 
developmental defects are also counted along with struc-
tural birth defects.
3. Integrating technologies such as mobile applications, data 
visualization, and geographic information systems to 
improve surveillance efficiency.
4. Extending surveillance programs to survey prevalence of 
risk factors in women of childbearing age (e.g., nutrition, 
infectious disease control) and birth defects–related disabil-
ity and mortality in the population.
5. Prioritizing birth defects surveillance as a part of national 
or regional health systems that are backed by ministries of 
health.
Reducing risk for birth defects
1. Raising public health awareness about evidence-based 
actions individuals and families can take to reduce their 
risks of having a child with birth defects. Health information 
should be culturally relevant and be accessible to all women 
regardless of their geographic location, education level, and 
socioeconomic status.
2. Educating women and girls, and men and boys, about their 
risks in a variety of settings and using different approaches. 
Schools, workplaces, and community centers can serve 
as places for delivering health education programs. For a 
population-based approach, use of social media, Web, and 
mobile technologies and platforms for popular culture are 
essential and innovative tools.
3. Maximizing the health of women and adolescent girls not 
only during pregnancy, but also aiming at the critical pre-
conception period, by focusing on exposures to teratogenic 
substances (e.g., tobacco, alcohol, recreational drugs, and 
medications), primary prevention, screening and treatment 
of infections, ensuring optimal nutrition, immunization 
and vector control, increasing access to family planning and 
contraception, and reducing environmental exposures 
and pollution.
4. Training health professionals in assessing and addressing 
risk factors for birth defects in a primary care setting.
5. Empowering women with health knowledge so that they 
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Fortifying staple foods
1. Implementing mandatory food fortification of staples with 
at least iron and folic acid in all countries in LAC.
2. Ensuring quality control of fortification standards through 
periodic monitoring of fortified foods in countries with exist-
ing food fortification programs. In addition, effectiveness of 
fortification should be evaluated through population-based 
biomarker analysis.
Preventing and treating infections
1. Investing in developing population-based infection 
control programs and policies (e.g., health education, 
immunizations, disease vector control, sanitation, sexual 
transmitted infections screening) through sustainable fund-
ing and resources.
2. Building laboratory and clinical care capacity for timely 
detection of infections through serological or other confir-
matory tests.
3. Improving access to infection prevention and treatment 
through primary health care programs and referral chains 
and ensuring coverage for everyone, regardless of their abil-
ity to pay.
Implementing newborn screening
1. Mandating newborn screening programs, supported by 
resource allocation for training and capacity-building, and 
monitoring for quality and cost-effectiveness.
2. Developing centralized mechanisms for screening using 
standardized approaches and promoting shared laboratory 
capacity at national and regional levels.
3. Improving the coverage of newborn screening to reach 
everyone, and ensuring inclusion of essential conditions in 
the screening panel, while also making sure that timely fol-
low-up and treatment are available based on the diagnosis.
Providing care and services for people 
with birth defects and disabilities
1. Establishing a holistic approach that is multidisciplinary and 
multisectoral, adequately meeting health, educational, occu-
pational, rehabilitation, and social needs of those with birth 
defects and disabilities throughout their life course, while 
increasing the number of trained professionals who can pro-
vide the aforementioned services.
2. Ensuring timely treatment, including surgery, medications, 
and nutrition, and providing universal coverage to those in 
need. In addition, home- and community-based follow-up is 
essential to maximize health and well-being.
Involving governments, civil society, 
and international agencies
1. Governments should support primary prevention where 
applicable and ensure integrated, population-based care 
programs. Policies, allocation of resources, and monitoring 
for quality and efficiency are essential parts of the govern-
ments’ role in reducing inequalities. Policies and programs 
should be sustained through relevant ministries within the 
governments, irrespective of changing political and eco-
nomic environments.
2. Civil society should actively engage in raising aware-
ness and advocate for reducing disparity, stigma, and 
isolation of individuals and families affected by birth defects 
and disabilities. Civil society, including parents, funders, and 
nongovernmental organizations, should hold governments 
accountable to provide universal access to care and services.
3. International agencies such as the United Nations Children's 
Fund (UNICEF), WHO, and the Pan American Health Orga-
nization (PAHO) should integrate and address birth defects. 
This will influence the governments to accelerate efforts that 
will help individuals with birth defects to survive, thrive, 
and transform their futures.
Advancing research on birth defects
1. Advancing current knowledge about the causes, diagnos-
tics, and treatment modalities through basic research.
2. Supporting epidemiologic research to better understand 
the role of factors such as sociodemographic, behavioral, 
nutritional, environmental, and genetic ones, as well as their 
interactions, in influencing the risk of birth defects.
3. Conducting implementation research on interventions for 
birth defects prevention and care in the population, and 
measuring the outcomes and impact of these interventions 
for a scale-up.
4. Ensuring sustained funding, training, and mentoring of 
researcher, multidisciplinary, and multicountry collabora-
tions that will support the aforementioned research activities 
in LAC.
DISCUSSION
This consensus statement from the 8th ICBD in 2017 is spe-
cific to Latin America and the Caribbean, and it is in alignment 
with the road map of the Global Strategy for Women's, Chil-
dren's and Adolescents’ Health (2016–2030) (8), as part of 
the Every Women Every Child global movement, and under 
the auspices of the United Nations SDG 3 (6). In addition, it 
builds on a global consensus statement from the 2015 Dar es 
Salaam 7th ICBD. The Dar es Salaam statement recognized 
that children with birth defects remain left behind in policies, 
programs, research, and funding, and that there is little to no 
action in a positive direction to address these gaps with birth 
defects (9). The 2017 consensus statement for LAC provides 
specific recommendations for birth defects prevention and care, 
while taking into account the region’s tremendous progress 
and unique challenges that still remain (10-15). The consensus 
is driven by the impact of the recent Zika virus epidemic on 
microcephaly and the needs of those affected (16-18), while 
recognizing the current status and advances made in LAC 
on birth defects surveillance through integrated approaches. 
Some examples of such advances include the Latin American 
Collaborative Study of Congenital Malformations (ECLAMC) 
(19) and PAHO’s successful role in promoting mandatory food 
fortification policies (20). The 2017 statement, however, takes 
into consideration the gaps that persist in the LAC region with 
regards to surveillance, diagnosis, research, access to care, pro-
gram coverage, monitoring, and evaluation for those with birth 
defects (21-23).
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Recently developed concepts in triple surveillance for 
integrated strategies to support and accelerate birth defect 
prevention (24) can be implemented in LAC utilizing exist-
ing surveillance infrastructure in the region. Although there is 
diversity in LAC in terms of geopolitical environments, health 
systems, and economies, most countries in the region share a 
common language and similar cultural contexts, which can be 
advantageous for developing regional collaborations and shar-
ing resources. Implementation and scale-up of evidence-based 
interventions using multisectoral and multidisciplinary col-
laborative approaches can be of benefit to populations across 
the region. Furthermore, LAC has high information and com-
munication technology utilization (25), and so must leverage 
technology and social media to advance and advocate for the 
approaches identified in this consensus statement.
Conclusion
Through this consensus statement, the authors and the 
endorsing attendees of the 2017 ICBD call upon governments, 
nongovernmental and civil society organizations, health care 
service organizations, institutions of higher education, donor 
agencies, researchers, and other stakeholders to take actions to 
improve birth defects prevention and care, as well as the quality 
of life of those living with birth defects and associated disabil-
ities in Latin America and the Caribbean. We also call on civil 
society in the LAC countries to demand accountability from 
their governments and other relevant stakeholders.
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Una declaración de consenso respecto a la vigilancia, prevención y atención 
de los defectos congénitos en América Latina y el Caribe
RESUMEN Los defectos congénitos contribuyen hasta con el 21% de la mortalidad de los menores de 5 años en América 
Latina y el Caribe (ALC); la epidemia de síndrome congénito por el virus del Zika aumentó esa carga. En el 
2001, la organización March of Dimes instituyó una serie de asambleas bienales denominadas Conferencia 
internacional sobre defectos congénitos y discapacidades en el mundo en desarrollo (ICBD). La más re- 
ciente, en el 2017, se llevó a cabo en Bogotá (Colombia) y contó con la presencia de más de 300 profesio-
nales, responsables de las políticas y donantes. Los asistentes a la conferencia, en su mayoría de América 
Latina y el Caribe, apoyaron un llamamiento a la acción en forma de una declaración de consenso. Dicha 
declaración enumera las acciones clave para potenciar al máximo la vigilancia, la prevención y la atención de 
los defectos congénitos en América Latina y el Caribe, a saber: 1) mejorar la vigilancia; 2) reducir los factores 
de riesgo asociados a defectos congénitos; 3) fortificar los alimentos de primera necesidad; 4) prevenir y 
tratar las infecciones asociadas con los defectos congénitos; 5) instituir programas de tamizaje a los recién 
nacidos; 6) prestar atención y servicios a las personas con defectos congénitos y discapacidades; 7) hacer 
participar a los gobiernos, la sociedad civil y los organismos internacionales; y 8) promover la investigación 
sobre los defectos congénitos. Se respaldaron la ejecución y la ampliación a mayor escala de las interven-
ciones basadas en evidencia, con enfoques colaborativos multisectoriales y multidisciplinarios. Los países de 
América Latina y el Caribe pueden aprovechar la tecnología y las redes sociales para impulsar y promover las 
estrategias mencionadas en la declaración de consenso. Por su parte, tanto los gobiernos como los organ-
ismos no gubernamentales pueden usar la declaración de consenso como una guía para adoptar medidas 
inmediatas para mejorar la calidad de vida de las personas con defectos congénitos y las discapacidades 
asociadas, en los países de América Latina y el Caribe.
Palabras clave Anomalías congénitas; epidemiología; atención médica; tamizaje neonatal; diagnóstico prenatal; prevención 
primaria; vigilancia; América Latina; Indias Occidentales.
Declaração de consenso sobre vigilância, prevenção e atenção de 
malformações congênitas na América Latina e no Caribe
RESUMO As malformações congênitas constituem 21% das causas de morte em crianças menores de 5 anos na 
América Latina e no Caribe (ALC) e este ônus tem sido agravado pela epidemia do vírus zika. Em 2001, 
a March of Dimes lançou uma série de encontros bienais denominada International Conference on Birth 
Defects and Disabilities in the Developing World (conferência internacional sobre malformações congênitas 
e deficiências no mundo em desenvolvimento, ICBD). A última ICBD foi realizada em Bogotá, na Colômbia, 
em 2017 e contou com a participação de mais de 300 profissionais, formuladores de políticas e doadores. Os 
participantes da conferência, na sua maioria da ALC, demonstraram apoio a um chamado à ação na forma de 
uma declaração de consenso. Nela, enumeram-se as principais ações para aumentar ao máximo a vigilância, 
prevenção e atenção às malformações congênitas na ALC: 1) melhorar a vigilância; 2) reduzir os riscos de 
malformações congênitas; 3) fortificar os gêneros alimentícios de primeira necessidade; 4) prevenir e tratar as 
infecções associadas às malformações congênitas; 5) implementar testes de detecção em recém-nascidos; 
6) prestar atendimento e serviços aos portadores de malformações congênitas e deficiências; 7) atrair a par-
ticipação de governos, sociedade civil e organismos internacionais e 8) incentivar o progresso da pesquisa 
na área de malformações congênitas. Foram endossadas a implementação e a expansão das intervenções 
com fundamentação científica usando enfoques colaborativos multissetoriais e multidisciplinares. Os países 
da ALC devem se valer de tecnologia e das mídias sociais para promover e defender os enfoques identi-
ficados na declaração de consenso. A declaração pode servir como guia aos governos e organismos não 
governamentais ao tomarem medidas imediatas para melhorar a qualidade de vida de quem vive com mal-
formações congênitas e deficiências associadas nos países da ALC.
Palavras-chave Anormalidades congênitas; epidemiologia; cuidados médicos; triagem neonatal; diagnóstico pré-natal; pre-
venção primária; vigilância; América Latina; Índias Ocidentais.
